HOSPITAL UNIVERSITARIO RUBER
Departamento
Copenhagen University Hospital
Copenhague, DinamarcaPublicaciones en colaboración con investigadores/as de Copenhagen University Hospital (5)
2024
2021
-
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
Annals of Oncology, Vol. 32, Núm. 12, pp. 1571-1581
2018
-
Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer
Investigational New Drugs, Vol. 36, Núm. 5, pp. 848-859
2016
-
Adjuvant bisphosphonates in early breast cancer: Consensus guidance for clinical practice from a European Panel
Annals of Oncology, Vol. 27, Núm. 3, pp. 379-390
-
The SafeBoosC phase II clinical trial: An analysis of the interventions related with the oximeter readings
Archives of Disease in Childhood: Fetal and Neonatal Edition, Vol. 101, Núm. 4, pp. F333-F338